Phase Ib/II-Study in Patients with metastatic castration-resistant
   Prostate Cancer (mCRPC) Phase Ib/II-Study of Pembrolizumab (MK-3475)
   Combination Therapies in Patients with mCRPC (KEYNOTE-365) - Study AP
   94/16 of the AUO

Document type:: Editorial Material
Author(s):: Rexer, H.; Wuelfing, C.; Retz, M.
Title:: Phase Ib/II-Study in Patients with metastatic castration-resistant Prostate Cancer (mCRPC) Phase Ib/II-Study of Pembrolizumab (MK-3475) Combination Therapies in Patients with mCRPC (KEYNOTE-365) - Study AP 94/16 of the AUO
Journal title abbreviation:: Urologe A
Year:: 2018
Journal volume:: 57
Journal issue:: 1
Pages contribution:: 120-121
Fulltext / DOI:: doi:10.1007/s00120-017-0556-4
Print-ISSN:: 0340-2592
TUM Institution:: Urologische Klinik und Poliklinik
BibTeX

Occurrences: